Quintero-Rivera Fabiola, Robson Caroline D, Reiss Rosemary E, Levine Deborah, Benson Carol, Mulliken John B, Kimonis Virginia E
Massachusetts General Hospital Center for Human Genetic Research, Genetics Training Program, Harvard Medical School, Boston, MA 02115, USA.
Prenat Diagn. 2006 Oct;26(10):966-72. doi: 10.1002/pd.1539.
Apert syndrome was diagnosed in a newborn with typical facial and digital features whose only detected prenatal abnormality had been agenesis of the corpus callosum. This prompted a review of the central nervous system findings in all cases of Apert syndrome treated at the Craniofacial Center Boston Children's Hospital between 1978 and 2004. Two of 30 patients with Apert syndrome had prenatal identification of mild dilatation of the lateral cerebral ventricles and complete agenesis of the corpus callosum (ACC) documented with both ultrasound and MRI. Both had the common S252W mutation of FGFR2. Though cranial and orbital malformations typical of Apert were eventually seen in these fetuses in the third-trimester, even in retrospect, these were not detectable at mid second-trimester, ultrasound screening for congenital malformations. Hand malformations also went undetected in the second-trimester despite extensive imaging by experienced radiologists. We conclude that prenatal ultrasonographic identification of mild ventriculomegaly or ACC should stimulate a careful search for features of Apert syndrome and prompt follow-up imaging to look for bony abnormalities that have later onset. Prenatal molecular testing for Apert mutations should be considered in cases of mild ventriculomegaly and ACC.
一名具有典型面部和手部特征的新生儿被诊断为Apert综合征,其唯一检测到的产前异常是胼胝体发育不全。这促使我们回顾了1978年至2004年间在波士顿儿童医院颅面中心接受治疗的所有Apert综合征病例的中枢神经系统检查结果。30例Apert综合征患者中有2例在产前经超声和磁共振成像(MRI)检查确定存在轻度侧脑室扩张和胼胝体完全发育不全(ACC)。这两名患者均具有FGFR2基因常见的S252W突变。尽管在孕晚期这些胎儿最终出现了典型的Apert综合征颅骨和眼眶畸形,但即便回顾性来看,在孕中期进行的先天性畸形超声筛查中这些畸形也无法被检测到。尽管有经验丰富的放射科医生进行了广泛的成像检查,手部畸形在孕中期同样未被发现。我们得出结论,产前超声检查发现轻度脑室扩大或ACC应促使仔细寻找Apert综合征的特征,并及时进行后续成像检查以寻找后期出现的骨骼异常。对于轻度脑室扩大和ACC的病例,应考虑进行Apert突变的产前分子检测。